Psilocybin for Treatment-Resistant Bipolar 2 Depression
Psilocybin is a naturally occurring psychedelic compound found in various mushroom species, commonly referred to as magic mushrooms or psilocybin mushrooms. When ingested, psilocybin is…
Psilocybin is a naturally occurring psychedelic compound found in various mushroom species, commonly referred to as magic mushrooms or psilocybin mushrooms. When ingested, psilocybin is…
Acute manic episodes in bipolar disorder should be considered as an emergency. Managing acute manic episodes requires a careful selection of medications to help stabilize…
Pramipexole is currently FDA-approved for Parkinson’s disease & Moderate-to-severe primary Restless Legs Syndrome but Pramipexole has promising data as an augmentation option for the management…
PSYCHIATRY EDUCATION FORUM ACADEMY’S BIPOLAR DISORDER MIXED FEATURES BASICS & BEYOND Bipolar disorder is a chronic mood disorder associated with various mood states including mania,…
Bipolar disorder is a complex mental health condition characterized by recurrent episodes of mania and depression. When a person with bipolar disorder experiences acute manic…
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: MANAGING BIPOLAR DISORDER IN ELDERLY Bipolar disorder can affect people of all ages, including elderly individuals. However, the symptoms…
In 2021: Based on in-vitro studies, FDA added the following Cardiac rhythm and conduction abnormalities warning to lamotrigine package insert: Lamotrigine could cause serious arrhythmias…
We continue our lecture series on Lithium Adverse Events Management with the discussion of Lithium Induced Hyperparathyroidism. The first case of Lithium induced hyperparathyroidism was…
We continue our lecture series on Lithium Adverse Events Management with the discussion of Lithium Induced Hypothyroidism. The antithyroid effects of lithium were recognized in…
A patient in his mid 30s was brought to the hospital by police for increased aggression towards his family members. On evaluation he reported a…
The perinatal period can increase the risk of mood symptoms recurrence for patients with bipolar disorder, including the risk of depressive episode recurrences and postpartum…
June 01, 2021 Today FDA approved LYBALVI for the treatment of: Schizophrenia in adults Bipolar I disorder in adults Acute treatment of manic or mixed…
Watch the following short 5 minutes video from Psychiatry Education Forum’s Bipolar Disorder Update 2020 Conference. This video will briefly discuss the important laboratory workup…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.